Orthostatic hypertension and major adverse events: a systematic review and meta-analysis
- PMID: 37202364
- DOI: 10.1093/eurjpc/zwad158
Orthostatic hypertension and major adverse events: a systematic review and meta-analysis
Abstract
Aims: The role of orthostatic hypertension (OHT) in cardiovascular disease (CVD) and mortality is unclear. We aimed to determine if this association exists through a systematic review and meta-analysis.
Methods and results: Study inclusion criteria included: (i) any observational/interventional studies of participants aged ≥18 years (ii) that assessed the relationship between OHT and (iii) at least one outcome measure-all-cause mortality (primary outcome), coronary heart disease, heart failure, stroke/cerebrovascular disease, or neurocognitive decline. MEDLINE, EMBASE, Cochrane, clinicaltrials.gov, and PubMed were independently searched by two reviewers (inception-19 April 2022). Critical appraisals were conducted using the Newcastle-Ottawa Scale. Random-effects meta-analysis was performed using a generic inverse variance method, and narrative synthesis or pooled results were presented as an odds or hazards ratio (OR/HR), with 95% confidence interval. Twenty studies (n = 61 669; 47.3% women) were eligible, of which 13 were included in the meta-analysis (n = 55 456; 47.3% women). Median interquartile range (IQR) follow-up for prospective studies was 7.85 (4.12, 10.83) years. Eleven studies were of good quality, eight fair, and one poor. Relative to orthostatic normotension (ONT), systolic OHT (SOHT) was associated with a significant 21% greater risk of all-cause mortality (HR: 1.21, 1.05-1.40), 39% increased risk of CVD mortality based on two studies (HR: 1.39, 1.05-1.84), and near doubled odds of stroke/cerebrovascular disease (OR: 1.94, 1.52-2.48). The lack of association with other outcomes may be due to weak evidence or low statistical power.
Conclusion: Patients with SOHT may have higher mortality risk relative to those with ONT and increased odds of stroke/cerebrovascular disease. Whether interventions can reduce OHT and improve outcomes should be explored.
Keywords: Cardiovascular disease; Meta-analysis; Mortality; Orthostatic hypertension; Systematic review.
Plain language summary
Orthostatic hypertension (OHT) is defined as an arbitrary rise in upper (systolic) and/or lower (diastolic) blood pressure readings on standing. We performed a thorough literature search and combined the evidence of impact of OHT on future adverse events, including death, heart attack, heart failure, stroke, falls, and impaired cognition. We found the following:Twenty studies that investigated the association between OHT and future adverse events. Of these, 13 were eligible to be included in the combined evidence (meta-analysis). This formed a total sample of 61 669 participants (47.3% women), of which 55 456 (47.3% women) were included in the meta-analysis.Systolic OHT (SOHT) was associated with a significant 21% increased risk for death from any cause, a 39% greater risk of death due to heart and blood vessel disease and near doubled odds of stroke or brain vessel disease. Furthermore, three of four studies found a significant association between SOHT and impaired cognition. Diastolic OHT was not found to be associated with these outcomes. The lack of association with other outcomes investigated may be due to weak evidence.Eleven studies were of good quality, eight fair, and one poor. Differences in study design, study criteria, and study populations mean that the results need interpreting with caution. Future robust studies can build on this evidence to assess if treatment to reduce OHT would improve future outcomes.
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: None declared.
Comment in
-
Orthostatic hypertension is an accessible, low-cost marker of cardiovascular risk.Eur J Prev Cardiol. 2025 May 12;32(7):608-609. doi: 10.1093/eurjpc/zwad219. Eur J Prev Cardiol. 2025. PMID: 37390468 No abstract available.
Similar articles
-
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.Cochrane Database Syst Rev. 2020 Sep 9;9(9):CD010315. doi: 10.1002/14651858.CD010315.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Nov 18;11:CD010315. doi: 10.1002/14651858.CD010315.pub5. PMID: 32905623 Free PMC article. Updated.
-
Association of orthostatic blood pressure response with incident heart failure: The Framingham Heart Study.PLoS One. 2022 Apr 22;17(4):e0267057. doi: 10.1371/journal.pone.0267057. eCollection 2022. PLoS One. 2022. PMID: 35452474 Free PMC article.
-
Omega-6 fats for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2018 Nov 29;11(11):CD011094. doi: 10.1002/14651858.CD011094.pub4. Cochrane Database Syst Rev. 2018. PMID: 30488422 Free PMC article.
-
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.JAMA. 2023 Oct 17;330(15):1459-1471. doi: 10.1001/jama.2023.18497. JAMA. 2023. PMID: 37847274 Free PMC article.
-
Cardiovascular Disorders and Falls Among Older Adults: A Systematic Review and Meta-Analysis.J Gerontol A Biol Sci Med Sci. 2024 Feb 1;79(2):glad221. doi: 10.1093/gerona/glad221. J Gerontol A Biol Sci Med Sci. 2024. PMID: 37738307 Free PMC article.
Cited by
-
The relationship between physical activity, orthostatic blood pressure reactions and subclinical atherosclerosis: the Swedish CArdioPulmonary bioImage Study (SCAPIS).J Hum Hypertens. 2025 Jun;39(6):392-399. doi: 10.1038/s41371-025-01022-8. Epub 2025 May 5. J Hum Hypertens. 2025. PMID: 40325166 Free PMC article.
-
Cardiopulmonary deconditioning and plasma volume loss are not sufficient to provoke orthostatic hypertension.Hypertens Res. 2024 Aug;47(8):2211-2216. doi: 10.1038/s41440-024-01710-x. Epub 2024 May 23. Hypertens Res. 2024. PMID: 38783144 Free PMC article.
-
Evaluation of the prevalence of cardiometabolic disorders (diabetes, hypertension, and hyperlipidemia) diagnosed, undiagnosed, treated, and treatment goal in the elderly: Bushehr Elderly Health Program (BEH).BMC Endocr Disord. 2024 Mar 5;24(1):29. doi: 10.1186/s12902-024-01561-0. BMC Endocr Disord. 2024. PMID: 38443972 Free PMC article.
-
Standing transthoracic echocardiography: a feasibility study.Echo Res Pract. 2025 May 20;12(1):12. doi: 10.1186/s44156-025-00075-2. Echo Res Pract. 2025. PMID: 40390110 Free PMC article.
-
Hypertension and orthostatic hypertension in 85-year-olds and associations with mortality and cognitive decline in a longitudinal cohort study.Sci Rep. 2025 Mar 27;15(1):10529. doi: 10.1038/s41598-025-94913-2. Sci Rep. 2025. PMID: 40148538 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous